FDA drug approvals
Every approval of a new drug, generic or biologic by the US Food and Drug Administration, newest first, under the company that holds the application today, from Drugs@FDA. 25,670 approvals on file, 13,159 held by companies on value.today.
Approvals, 2026
724
all applicants
50
New uses approved, 2026
196
efficacy supplements
Approvals, 2025
824
50 new molecules
FDA approvals
5,406 approvals, newest first.
| Approved | Drug | Held by | Kind |
|---|---|---|---|
| 2026-11-10 | Pimjetminew moleculePimicotinib · Capsule · Oral · NDA220414 | 🇩🇪 Merck KGaA | New drug (NDA) |
| 2026-11-09 | MultibicMultibic · Solution · NDA219457 | FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC | New drug (NDA) |
| 2026-11-09 | OxderysDoxorubicin Hydrochloride · Vial · Multidose · NDA221093 | AVYXA HOLDINGS | New drug (NDA) |
| 2026-11-09 | Sunharbonew moleculepriority reviewAsundexian · Tablet · Film Coated · NDA221291 | 🇩🇪 Bayer AG | New drug (NDA) |
| 2026-10-29 | AxycisCisplatin · Liquid · NDA220748 | AVYXA HOLDINGS, LLC. | New drug (NDA) |
| 2026-10-20 | Hibsagonew moleculepriority reviewBepirovirsen · Injection · Solution · NDA221276 | 🇬🇧 GSK plc | New drug (NDA) |
| 2026-10-19 | CienbySodium Ctirate · Solution · Injection · NDA219455 | FRESENIUS MEDCL CARE | New drug (NDA) |
| 2026-10-19 | CalrezdyCalcuim Chloride · Solution · Injection · NDA219456 | FRESENIUS MEDCL CARE | New drug (NDA) |
| 2026-10-16 | BrytlyApraclonidine Hydrochloride · Solution/Drops · Ophthalmic · NDA220341 | 🇨🇭 Alcon Inc. | New drug (NDA) |
| 2026-10-16 | YulzetyRivaroxaban · Suspension · Oral · NDA221033 | ROSEMONT PHARMS | New drug (NDA) |
| 2026-10-15 | EvoxacCevimeline Hydrochloride · Solution · Oral · NDA221183 | COSETTE | New drug (NDA) |
| 2026-10-09 | Isovue ReadiIopamidol · Solution · Oral · NDA220583 | BRACCO | New drug (NDA) |
| 2026-10-09 | Hovilprinew moleculepriority reviewPritelivir Mesylate · Tablet · Oral · NDA221154 | AICURIS ANTI-INFECT | New drug (NDA) |
| 2026-10-08 | WeltruzaOlanzapine · Powder · Subcutaneous · NDA219007 | 🇮🇱 Teva Pharmaceutical Industries Limited | New drug (NDA) |
| 2026-10-08 | Breztri AerosphereBudesonide, Formoterol Fumarate, Glycopyrrolate · Aerosol, Metered · Inhalation · NDA220290 | 🇬🇧 AstraZeneca PLC | New drug (NDA) |
| 2026-10-01 | TrabectedinTrabectedin · Powder · Intravenous · NDA219617 | EVER | New drug (NDA) |
| 2026-09-28 | Emcitatenew moleculepriority reviewTiratricol · Tablet, For Suspension · Oral · NDA220963 | RARE THYROID | New drug (NDA) |
| 2026-09-25 | ZueinoDiclofenac Sodium · Solution · Intravenous · NDA218379 | ADVENTAPHARMA | New drug (NDA) |
| 2026-09-25 | Juvmo, Juvmo (Copackaged)new moleculeTavapadon · Tablet · Oral · NDA220415 | 🇺🇸 AbbVie Inc. | New drug (NDA) |
| 2026-09-25 | LamliqueLamotrigine Hemifumarate · Suspension · Oral · NDA221109 | AZURITY | New drug (NDA) |
| 2026-09-25 | Atebrioznew moleculepriority reviewZilurgisertib Fumarate · Tablet · Oral · NDA221198 | 🇺🇸 Mirum Pharmaceuticals, Inc. | New drug (NDA) |
| 2026-09-23 | Lyrfigtunew moleculepriority reviewLirafugratinib Hydrochloride · Capsule · Oral · NDA220425 | ELEVAR | New drug (NDA) |
| 2026-09-22 | Carbon Dioxide, UspCarbon Dioxide, Usp · Gas · Inhalation · NDA222000 | AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES | New drug (NDA) |
| 2026-09-14 | BexlutryLutetium Lu-177 Dotatate · Solution · Intravenous · NDA218525 | CURIUM | New drug (NDA) |
| 2026-09-11 | Pixclaranew moleculepriority reviewFloretyrosine F-18 · Solution · Intravenous · NDA218592 | 🇦🇺 Telix Pharmaceuticals Limited | New drug (NDA) |
| 2026-09-04 | Etcamahnew moleculeCamizestrant · Tablet · Oral · NDA220359 | 🇬🇧 AstraZeneca PLC | New drug (NDA) |
| 2026-09-03 | Zanvastronew moleculepriority reviewZilganersen Sodium · Solution · Intrathecal · NDA220210 | 🇺🇸 Ionis Pharmaceuticals, Inc. | New drug (NDA) |
| 2026-09-03 | OmcazioCabozantinib Laurylsulfate · Capsule · Oral · NDA220613 | HANDA ONCOL | New drug (NDA) |
| 2026-08-28 | Mimrylonew moleculepriority reviewRusfertide Acetate · Powder · Subcutaneous · NDA220605 | TAKEDA PHARMS AM | New drug (NDA) |
| 2026-08-27 | Lisrayanew moleculepriority reviewBrepocitinib Tosylate · Tablet · Oral · NDA220106 | PRIOVANT THERAP | New drug (NDA) |
| 2026-08-27 | Bixlenvopriority reviewBictegravir Sodium, Lenacapavir Sodium · Tablet · Oral · NDA221104 | 🇺🇸 Gilead Sciences, Inc. | New drug (NDA) |
| 2026-08-27 | Bixlenvo Sunlenca Starter Pack (Copackaged)Bictegravir Sodium, Lenacapavir Sodium, Lenacapavir Sodium · Tablet · Oral · NDA221443 | 🇺🇸 Gilead Sciences, Inc. | New drug (NDA) |
| 2026-08-26 | VobrigLeuprolide Acetate · Solution · Subcutaneous · NDA213225 | 🇮🇳 Sun Pharmaceutical Industries Limited | New drug (NDA) |
| 2026-08-26 | Rasonquenew moleculepriority reviewDaraxonrasib · Tablet · Oral · NDA220910 | 🇺🇸 Revolution Medicines, Inc. | New drug (NDA) |
| 2026-08-14 | Sodium BicarbonateSodium Bicarbonate · Solution · Intravenous · NDA218524 | 🇺🇸 Baxter International Inc. | New drug (NDA) |
| 2026-08-13 | Tauklarifynew moleculeFlorquinitau F-18 · Solution · Intravenous · NDA220496 | CERVEAU LANTHEUS | New drug (NDA) |
| 2026-08-13 | Zenbexusnew moleculepriority reviewIberdomide Hydrochloride · Capsule · Oral · NDA221075 | 🇺🇸 Bristol-Myers Squibb Company | New drug (NDA) |
| 2026-08-09 | Nitrous Oxide, UspNitrous Oxide · Gas · Inhalation · NDA221892 | LINDE GAS EQUIP | New drug (NDA) |
| 2026-08-05 | Orzeyfulnew moleculepriority reviewOveporexton · Tablet · Oral · NDA220860 | 🇯🇵 Takeda Pharmaceutical Company Limited | New drug (NDA) |
| 2026-07-29 | GlycophosSodium Glycerophosphate · Solution · Intravenous · NDA220381 | 🇩🇪 Fresenius SE & Co. KGaA | New drug (NDA) |
| 2026-07-29 | QlonilikClonidine Hydrochloride · Solution · Oral · NDA221094 | CMP DEV LLC | New drug (NDA) |
| 2026-07-28 | Gwyn LoEthinyl Estradiol, Norelgestromin · System · Transdermal · NDA219990 | 🇺🇸 Viatris Inc. | New drug (NDA) |
| 2026-07-24 | Simtriyonew moleculepriority reviewCentanafadine Hydrochloride · Capsule, Extended Release · NDA218145 | 🇯🇵 Otsuka Holdings Co., Ltd. | New drug (NDA) |
| 2026-07-24 | Tylenol With NaproxenAcetaminophen, Naproxen Sodium · Tablet · Oral · NDA219962 | KENVUE BRANDS | New drug (NDA) |
| 2026-07-22 | Jideytronew moleculeZidesamtinib · Tablet · Oral · NDA220185 | 🇺🇸 Nuvalent, Inc. | New drug (NDA) |
| 2026-07-19 | AirAir · Gas · Inhalation · NDA221805 | NOBLE GAS SOLUTIONS INC. | New drug (NDA) |
| 2026-07-15 | Lipfendranew moleculepriority reviewEnlicitide Decanoate · Tablet · Oral · NDA220848 | MSD | New drug (NDA) |
| 2026-07-14 | Revtorpyknew moleculepriority reviewGedatolisib · Powder · Intravenous · NDA219908 | 🇺🇸 Celcuity Inc. | New drug (NDA) |
| 2026-07-10 | ZyogreenIndocyanine Green · Solution · Intravenous, Interstitial · NDA218579 | PROVEPHARM SAS | New drug (NDA) |
| 2026-07-09 | Sodium BicarbonateSodium Bicarbonate · Solution · Intravenous · NDA220790 | 🇺🇸 Amneal Pharmaceuticals, Inc. | New drug (NDA) |
Most approvals, last 12 months
Companies on value.today.
Source: US Food and Drug Administration, Drugs@FDA (openFDA) · as of Nov 13, 2026. Approvals follow the application to its current holder, so an acquired company's approvals appear under the buyer. Vaccines and blood products are approved by another FDA centre and are not listed. How it is counted